Xavier Montalban is Chair of the Department of Neurology-Neuroimmunology of the Vall d’Hebron University Hospital and Director of the Multiple Sclerosis Centre of Catalonia and Professor of Neurology of the Universitat Autònoma de Barcelona (UAB). He is a member of a number of scientific organizations, Vice-president of the Multiple Sclerosis Foundation, and sits on the advisory board and the scientific committee of the Multiple Sclerosis International Federation, and the European Charcot Foundation. Since 2003, he has been a member of the advisory committee on clinical trials of new agents of the National Multiple Sclerosis Society in the United States. He has been a member since 2009 and currently serves as Vicepresident of the ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis). Xavier Montalban is the current director for the Neuroimmunology content of Revista de Neurología, the largest distribution Neurology journal in Spanish, and serves as a member of several editorial boards of both national and international specialist journals of which he is also a peer-reviewer. He has published over 200 original contributions in international journals and has authored a number of book chapters. His current research interests include immune mechanisms in MS, cognitive dysfunction in MS, new intervention strategies, genetic characterization and pharmacogenomics of treatment response and prognostic factors of MS. He has participated both in the design and execution of several phase II and phase III clinical trials, and is member of several safety and steering committees.

Neurology-Neuroimmunology